Allspring Global Investments Holdings, LLC Mersana Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.3 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$3.08 - $9.55 $8,781 - $27,227	2,851 Added 155.79%	4,681 $15,000
Q1 2023 Apr 13, 2023	BUY	$4.0 - $7.02 $6,704 - $11,765	1,676 Added 1088.31%	1,830 $7,000
Q3 2022 Oct 26, 2022	BUY	$4.63 - $8.0 $713 - $1,232	154 New	154 $1,000

Others Institutions Holding MRSN

# of Institutions

136

Shares Held

101M

Call Options Held

77.2K

Put Options Held

453K

Nextech Invest Ag

12.1M
Shares

$5.55 Million
3.22% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$5.21 Million
0.76% of portfolio
Vr Adviser, LLC New York, NY

10.3M
Shares

$4.72 Million
2.42% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$3.99 Million
3.35% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$3.86 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $44.7M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account